Author Voors, Adriaan A.

1 to 20 of 34 Items

2006 | Journal Article
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial
Bakris, G. L.; Ruilope, L.; Locatelli, F.; Ptaszynska, A.; Pieske, B. M.; Raz, I. & Voors, A. A. et al. (2006)
Journal of Human Hypertension, 20(9) pp. 693-700. DOI: https://doi.org/10.1038/sj.jhh.1002050
Details DOI PMID PMC WoS

2015 | Journal Article
Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial
Tang, W. H. W.; Dupont, M.; Hernandez, A. F.; Voors, A. A.; Hsu, A. P.; Felker, G. M. & Butler, J. et al. (2015)
JACC Heart Failure, 3(1) pp. 40-49. DOI: https://doi.org/10.1016/j.jchf.2014.06.014
Details DOI PMID PMC WoS

2015 | Journal Article
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
Pitt, B.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al. (2015)
European Journal of Heart Failure, 17(2) pp. 224-232. DOI: https://doi.org/10.1002/ejhf.218
Details DOI PMID PMC WoS

2016 | Journal Article | Erratum
Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482-489]
Anker, S. D. ; Schroeder, S.; Atar, D.; Bax, J. J.; Ceconi, C.; Cowie, M. R. & Crisp, A. et al. (2016)
European Journal of Heart Failure, 18(6) pp. 727-727. DOI: https://doi.org/10.1002/ejhf.591
Details DOI

2016 | Journal Article
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P.; Voors, A. A.; Anker, S. D. ; Bueno, H.; Cleland, J. G. F.; Coats, A. J. S. & Falk, V. et al. (2016)
European Journal of Heart Failure, 18(8) pp. 891-975. DOI: https://doi.org/10.1002/ejhf.592
Details DOI

2016 | Journal Article
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
Voors, A. A.; Anker, S. D. ; Cleland, J. G.; Dickstein, K.; Filippatos, G.; van der Harst, P. & Hillege, H. L. et al. (2016)
European Journal of Heart Failure, 18(6) pp. 716-726. DOI: https://doi.org/10.1002/ejhf.531
Details DOI

2016 | Journal Article |
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Filippatos, G. S.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al. (2016)
European Heart Journal, 37(27) pp. 2105-2114. DOI: https://doi.org/10.1093/eurheartj/ehw132
Details DOI PMID PMC WoS

2017 | Journal Article
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
Voors, A. A.; Ouwerkerk, W.; Zannad, F.; van Veldhuisen, D. J.; Samani, N. J.; Ponikowski, P. & Ng, L. L. et al. (2017)
European Journal of Heart Failure, 19(5) pp. 627-634. DOI: https://doi.org/10.1002/ejhf.785
Details DOI

2017 | Journal Article
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure
Bayes-Genis, A.; Núñez, J.; Zannad, F.; Ferreira, J. P.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al. (2017)
Journal of the American College of Cardiology, 70(17) pp. 2128-2136. DOI: https://doi.org/10.1016/j.jacc.2017.08.057
Details DOI

2017 | Journal Article
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure
Emmens, J. E.; Jones, D. J.; Cao, T. H.; Chan, D. C.; Romaine, S. P.; Quinn, P. A. & Anker, S. D. et al. (2017)
European Journal of Heart Failure, 20(2) pp. 260-267. DOI: https://doi.org/10.1002/ejhf.1101
Details DOI

2017 | Journal Article |
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
van Veldhuisen, D. J.; Ponikowski, P.; van der Meer, P.; Metra, M.; Böhm, M.; Doletsky, A. & Voors, A. A. et al. (2017)
Circulation, 136(15) pp. 1374-1383. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.027497
Details DOI

2017 | Journal Article |
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure
Brown, D. A.; Perry, J. B.; Allen, M. E.; Sabbah, H. N.; Stauffer, B. L.; Shaikh, S. R. & Cleland, J. G. F. et al. (2017)
Nature Reviews Cardiology, 14(4) pp. 238-250. DOI: https://doi.org/10.1038/nrcardio.2016.203
Details DOI PMID PMC

2018 | Journal Article
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
Streng, K. W.; Nauta, J. F.; Hillege, H. L.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al. (2018)
International Journal of Cardiology, 271 pp. 132-139. DOI: https://doi.org/10.1016/j.ijcard.2018.04.001
Details DOI

2018 | Journal Article
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
Beusekamp, J. C.; Tromp, J.; van der Wal, H. H.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al. (2018)
European Journal of Heart Failure, 20(5) pp. 923-930. DOI: https://doi.org/10.1002/ejhf.1079
Details DOI

2018 | Journal Article
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
ter Maaten, J. M.; Voors, A. A.; Damman, K.; van der Meer, P.; Anker, S. D.; Cleland, J. G. & Dickstein, K. et al. (2018)
International Journal of Cardiology, 253 pp. 84-90. DOI: https://doi.org/10.1016/j.ijcard.2017.10.010
Details DOI

2018 | Journal Article
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure
Ouwerkerk, W.; Zwinderman, A. H.; Ng, L. L.; Demissei, B.; Hillege, H. L.; Zannad, F. & van Veldhuisen, D. J. et al. (2018)
Journal of the American College of Cardiology, 71(4) pp. 386-398. DOI: https://doi.org/10.1016/j.jacc.2017.11.041
Details DOI

2019 | Journal Article
Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study
Ferreira, J. P.; Metra, M.; Anker, S. D. ; Dickstein, K.; Lang, C. C.; Ng, L. & Samani, N. J. et al. (2019)
European Journal of Heart Failure, 21(2) pp. 218-226. DOI: https://doi.org/10.1002/ejhf.1380
Details DOI

2019 | Journal Article
Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure
ter Maaten, J. M.; Kremer, D.; Demissei, B. G.; Struck, J.; Bergmann, A.; Anker, S. D. & Ng, L. L. et al. (2019)
European Journal of Heart Failure, 21(6) pp. 732-743. DOI: https://doi.org/10.1002/ejhf.1437
Details DOI

2019 | Journal Article
Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF
Suzuki, T.; Yazaki, Y.; Voors, A. A.; Jones, D. J.; Chan, D. C.; Anker, S. D. & Cleland, J. G. et al. (2019)
European Journal of Heart Failure, 21(7) pp. 877-886. DOI: https://doi.org/10.1002/ejhf.1338
Details DOI

Göttingen All

issue date

ASC DESC

10 20 50 100